126 related articles for article (PubMed ID: 38325006)
1. Novel dual-target FAAH and TRPV1 ligands as potential pharmacotherapeutics for pain management.
Qiao Z; Liu S; Zhai W; Jiang L; Ma Y; Zhang Z; Wang B; Shao J; Qian H; Zhao F; Yan L
Eur J Med Chem; 2024 Mar; 267():116208. PubMed ID: 38325006
[TBL] [Abstract][Full Text] [Related]
2. Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics.
Maione S; Costa B; Piscitelli F; Morera E; De Chiaro M; Comelli F; Boccella S; Guida F; Verde R; Ortar G; Di Marzo V
Pharmacol Res; 2013 Oct; 76():98-105. PubMed ID: 23911581
[TBL] [Abstract][Full Text] [Related]
3. A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis.
Malek N; Mrugala M; Makuch W; Kolosowska N; Przewlocka B; Binkowski M; Czaja M; Morera E; Di Marzo V; Starowicz K
Pain; 2015 May; 156(5):890-903. PubMed ID: 25719612
[TBL] [Abstract][Full Text] [Related]
4. A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase.
Carey LM; Slivicki RA; Leishman E; Cornett B; Mackie K; Bradshaw H; Hohmann AG
Mol Pain; 2016; 12():. PubMed ID: 27178246
[TBL] [Abstract][Full Text] [Related]
5. Paracetamol analogues conjugated by FAAH induce TRPV1-mediated antinociception without causing acute liver toxicity.
Å Nilsson JL; Mallet C; Shionoya K; Blomgren A; Sundin AP; Grundemar L; Boudieu L; Blomqvist A; Eschalier A; Nilsson UJ; Zygmunt PM
Eur J Med Chem; 2021 Mar; 213():113042. PubMed ID: 33257173
[TBL] [Abstract][Full Text] [Related]
6. Arylboronic acids as dual-action FAAH and TRPV1 ligands.
Morera E; Di Marzo V; Monti L; Allarà M; Schiano Moriello A; Nalli M; Ortar G; De Petrocellis L
Bioorg Med Chem Lett; 2016 Mar; 26(5):1401-5. PubMed ID: 26850005
[TBL] [Abstract][Full Text] [Related]
7. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.
Maione S; De Petrocellis L; de Novellis V; Moriello AS; Petrosino S; Palazzo E; Rossi FS; Woodward DF; Di Marzo V
Br J Pharmacol; 2007 Mar; 150(6):766-81. PubMed ID: 17279090
[TBL] [Abstract][Full Text] [Related]
8. Novel dual-target μ‑opioid and TRPV1 ligands as potential pharmacotherapeutics for pain management.
Gao M; Zhang Y; Wang B; Guo N; Shao L; Zhai W; Jiang L; Wang Q; Qian H; Yan L
Bioorg Chem; 2023 Feb; 131():106335. PubMed ID: 36603243
[TBL] [Abstract][Full Text] [Related]
9. The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice.
Costa B; Bettoni I; Petrosino S; Comelli F; Giagnoni G; Di Marzo V
Pharmacol Res; 2010 Jun; 61(6):537-46. PubMed ID: 20138997
[TBL] [Abstract][Full Text] [Related]
10. Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT).
Bashashati M; Fichna J; Piscitelli F; Capasso R; Izzo AA; Sibaev A; Timmermans JP; Cenac N; Vergnolle N; Di Marzo V; Storr M
Neurogastroenterol Motil; 2017 Dec; 29(12):. PubMed ID: 28695708
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid amide hydrolase-dependent generation of antinociceptive drug metabolites acting on TRPV1 in the brain.
Barrière DA; Mallet C; Blomgren A; Simonsen C; Daulhac L; Libert F; Chapuy E; Etienne M; Högestätt ED; Zygmunt PM; Eschalier A
PLoS One; 2013; 8(8):e70690. PubMed ID: 23940628
[TBL] [Abstract][Full Text] [Related]
12. New N-arachidonoylserotonin analogues with potential "dual" mechanism of action against pain.
Ortar G; Cascio MG; De Petrocellis L; Morera E; Rossi F; Schiano-Moriello A; Nalli M; de Novellis V; Woodward DF; Maione S; Di Marzo V
J Med Chem; 2007 Dec; 50(26):6554-69. PubMed ID: 18027904
[TBL] [Abstract][Full Text] [Related]
13. The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats.
de Novellis V; Palazzo E; Rossi F; De Petrocellis L; Petrosino S; Guida F; Luongo L; Migliozzi A; Cristino L; Marabese I; Starowicz K; Di Marzo V; Maione S;
Neuropharmacology; 2008 Dec; 55(7):1105-13. PubMed ID: 18616956
[TBL] [Abstract][Full Text] [Related]
14. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
15. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.
Starowicz K; Makuch W; Korostynski M; Malek N; Slezak M; Zychowska M; Petrosino S; De Petrocellis L; Cristino L; Przewlocka B; Di Marzo V
PLoS One; 2013; 8(4):e60040. PubMed ID: 23573230
[TBL] [Abstract][Full Text] [Related]
16. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
Neuropsychopharmacology; 2009 Feb; 34(3):593-606. PubMed ID: 18580871
[TBL] [Abstract][Full Text] [Related]
17. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K
Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920
[TBL] [Abstract][Full Text] [Related]
18. Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy.
Silva M; Martins D; Charrua A; Piscitelli F; Tavares I; Morgado C; Di Marzo V
Neuropharmacology; 2016 Aug; 107():49-57. PubMed ID: 26965218
[TBL] [Abstract][Full Text] [Related]
19. The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis.
Navarria A; Tamburella A; Iannotti FA; Micale V; Camillieri G; Gozzo L; Verde R; Imperatore R; Leggio GM; Drago F; Di Marzo V
Pharmacol Res; 2014 Sep; 87():151-9. PubMed ID: 24861565
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey.
Kawahara H; Drew GM; Christie MJ; Vaughan CW
Br J Pharmacol; 2011 Jul; 163(6):1214-22. PubMed ID: 21175570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
